B

    Biovie Inc (BIVI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.28
    +0.12 (+5.56%)

    Market Cap: $18.25M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    57%(13/23)
    Avg Surprise
    -46.54%
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    		$-0.70$-0.52-34.62%Miss+93.7%
    Mar 26
    		$-0.70$-0.77+9.27%Beat+53.4%
    Dec 25
    		$-0.77$-0.92+16.71%Beat+83.3%
    Sep 25
    		$-0.98$-0.79-24.05%Miss-40.1%
    Jun 25
    		$-11.05$-3.60-206.94%Miss-1284.4%
    Mar 25
    		$-1.50N/A+53.13%Beat+92.5%
    Dec 24
    		$-4.60N/A+71.25%Beat+79.1%
    Sep 24
    		$-0.70$-0.27-159.15%Miss+97.6%
    Jun 24
    		$-0.80$-0.15-432.13%Miss+96.5%
    Mar 24
    		$-20.00$-25.00+20.00%Beat+53.5%
    Dec 23
    		$-22.00$-27.50+20.00%Beat+56.0%
    Sep 23
    		$-29.00$-31.00+6.45%Beat+23.7%
    Jun 23
    		$-23.00$-40.00+42.50%Beat-6869.7%
    Mar 23
    		$-43.00$-35.50-21.13%Miss-53.6%
    Dec 22
    		$-50.00$-25.25-98.02%Miss-127.3%
    Sep 22
    		$-38.00$-28.50-33.33%Miss-16421.7%
    Jun 22
    		$-0.33$-0.37+10.81%Beat+100.0%
    Mar 22
    		$-28.00N/A+60.56%Beat-27.3%
    Dec 21
    		$-22.00$-41.00+46.34%Beat+0.0%
    Sep 21
    		$-0.23$-0.23+0.00%Beat+93.0%
    Jun 21
    		$-1018.77$-232.00-339.13%Miss-27584.0%
    Mar 21
    		$-22.00$-23.00+4.35%Beat-31328.6%
    Dec 20
    		$-22.00$-12.00-83.33%Miss-1805.4%
    Sep 20
    		$-3.28N/AN/ABeat+35.2%
    Jun 20
    		$-3.68N/AN/ABeat-1372.0%
    Mar 20
    		$-0.07N/AN/ABeat+72.0%
    Dec 19
    		$1.29N/AN/ABeat+479.4%
    Sep 19
    		$-5.06N/AN/ABeat-2430.0%
    Jun 19
    		$-0.25N/AN/ABeat-26.6%
    Mar 19
    		$-0.25N/AN/ABeat+66.0%
    Dec 18
    		$-0.34N/AN/ABeat+61.9%
    Sep 18
    		$-0.20N/AN/ABeat+69.8%
    Jun 18
    		$-0.20N/AN/ABeat+77.8%
    Mar 18
    		$-0.73N/AN/ABeat-21.8%
    Dec 17
    		$-0.89N/AN/ABeat-266.1%
    Sep 17
    		$-0.66N/AN/ABeat-29.6%
    Jun 17
    		$-0.89N/AN/ABeat-
    Mar 17
    		$-0.60N/AN/ABeat-
    Dec 16
    		$-0.24N/AN/ABeat-
    Sep 16
    		$-0.51N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.72EV/EBITDA-11.66x
    Price/FCF-0.90xFCF Yield-110.61%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-150.80%ROIC-130.12%
    Financial Health
    Debt/Equity0.01xInterest Coverage-1079.03x
    Current Ratio9.97xQuick Ratio9.97x
    Trading Statistics
    Beta0.67Avg Volume13.42M
    52-Week High$3.7952-Week Low$0.82

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.91
    SMA 20$1.67
    SMA 50$1.72
    SMA 200$1.48
    EMA 10$1.98
    EMA 20$1.80
    EMA 50$1.69
    EMA 200$2.19

    MACD

    Line: 0.17Signal: 0.08Hist: 0.10

    ADX

    ADX: 39.3+DI: 43.7-DI: 12.6

    Aroon & PSAR

    Aroon Up48.0
    Aroon Down32.0
    PSAR$3.32

    Bollinger Bands

    Upper Band$2.56
    Lower Band$0.78
    %B Position10640%(Upper)
    Band Width0.84

    RSI (14-Day)

    Neutral
    62.9

    Momentum Oscillators

    Stoch %K44.5
    Stoch %D43.1
    Williams %R-53.1
    ROC (10d)94.9%
    Momentum1.11
    CCI (20d)105.8
    MFI (14d)94.3

    Volatility Measures

    ATR (14d)$0.39(17.2%)
    StdDev (20d)0.44
    Hist Vol296.5%(High)

    Volume Flow

    VWAP$2.35
    OBV219.1M
    AD Line5.2B
    CMF (20d)-0.397

    Volume Metrics

    Avg Vol (20d)14.1M
    Vol Ratio0.1x(Low)
    VWMA (20d)$1.58

    Pivot Points

    R3$2.38
    R2$2.32
    R1$2.24
    Pivot Point$2.17
    S1$2.09
    S2$2.03
    S3$1.95

    Advanced Oscillators

    TSI13.77
    Ultimate Osc46.3
    KST202.17

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0$0$57,344$0$0$57,344$57,344$0$57,344$0$67,104
    Gross Profit$0$0$0$-57,344$0$0$-57,344$-57,344$0$-57,344$0$-67,104
    Operating Expenses$5.39M$6.26M$5.28M$3.61M$2.99M$7.29M$4.12M$4.73M$7.73M$8.78M$4.12M$17.69M
    R&D$3.18M$4.27M$2.94M$1.22M$1.34M$4.70M$1.99M$2.05M$5.70M$6.47M$1.99M$12.25M
    SG&A$2.15M$1.94M$2.29M$2.38M$1.59M$2.53M$2.07M$2.68M$1.97M$2.25M$2.07M$5.38M
    Operating Income$-5,385,377$-6,262,305$-5,284,595$-3,663,085$-2,988,204$-7,292,829$-4,122,082$-4,790,300$-7,732,055$-8,781,408$-4,122,082$-17,691,164
    Interest Income$121,045$198,797$199,027$178,942$197,494$253,036$223,557$272,517$183,933$218,029$223,557$-301,921
    Interest Expense$5,967$5,967$1,989$4,998$4,998$66,700$256,024$439,943$628,711$820,600$256,024$1.85M
    Income Before Tax$-5,270,299$-6,069,475$-5,087,557$-3,489,141$-2,788,418$-7,112,529$-4,152,032$-4,940,794$-8,067,830$-8,401,445$-4,152,032$-23,076,076
    Income Tax Expense$0$0$0$7.16M$0$0$-4,477,073$439,943$0$820,600$0$0
    Net Income$-5,270,299$-6,069,475$-5,087,557$-3,489,141$-2,788,418$-7,112,529$-4,152,032$-4,940,794$-8,067,830$-8,401,445$-4,152,032$-23,076,076
    EBITDA$-5,328,032$-6,204,961$-5,227,251$-3,426,799$-2,923,569$-7,241,521$-3,838,664$-4,443,507$-7,565,708$-7,523,501$-4,052,765$-20,792,623
    EBIT$-5,385,377$-6,262,305$-5,284,595$-3,484,143$-2,980,914$-7,298,865$-3,896,008$-4,500,851$-7,623,052$-7,580,845$-4,119,565$-20,927,984
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about BIVI

    News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

    This article lists 12 healthcare stocks that experienced significant movement in Thursday's pre-market session. It categorizes them into gainers and losers, providing their stock performance, current share price, and market capitalization. Some entries also mention recent earnings report dates.

    Sahm•8/21/26•
    Somewhat-Bullish

    12 Health Care Stocks Moving In Wednesday's Intraday Session

    This article lists 12 healthcare stocks that experienced significant movement during Wednesday's intraday trading session. It highlights several gainers, including ZeroStack, Tenon Medical, Moderna, BioVie, Cypherpunk Technologies, and Femasys, with their respective percentage increases and market caps. The article also identifies losers such as INVO Fertility, Valion Bio, Conexeu Sciences, Iridex, Intelligent Bio Solutions, and Alpha Compute, along with their declines and market values.

    Sahm•8/20/26•
    Neutral

    New 8.4% BioVie (NASDAQ: BIVI) stake sits entirely in warrants

    Alta Partners LLC has reported a significant 8.4% beneficial ownership in BioVie Inc. (NASDAQ: BIVI) Class A Common Stock through a Schedule 13G filing. This stake, totaling 687,321 shares, is entirely comprised of shares issuable upon the exercise of warrants, rather than currently outstanding common shares. Alta Partners LLC maintains sole voting and dispositive power over these shares, indicating a notable but non-controlling position in BioVie.

    Stock Titan•8/19/26•
    Neutral

    Morgan Stanley (BIVI) discloses 896,822 BioVie shares, an 11.9% stake

    Morgan Stanley and Morgan Stanley Smith Barney LLC have reported beneficial ownership of 896,822 shares of BioVie Inc. Class A common stock, representing an 11.9% stake. This disclosure, made via a Schedule 13G/A filing, indicates shared dispositive power over these shares but no sole voting or dispositive power. The filing classifies Morgan Stanley as a parent holding company and Morgan Stanley Smith Barney LLC as a broker-dealer and investment adviser.

    Stock Titan•8/8/26•
    Neutral

    Morgan Stanley (BIVI) discloses 8.0% beneficial stake in BioVie Class A shares

    Morgan Stanley and its subsidiary Morgan Stanley Smith Barney LLC have reported a beneficial ownership of 605,472 shares of BioVie Inc. Class A common stock, which represents an 8.0% stake as of June 30, 2026. The filing, a SCHEDULE 13G, indicates that both entities hold 0 shares with sole voting or dispositive power, but have 1 share with shared voting power and all 605,472 shares with shared dispositive power, implying joint control within Morgan Stanley's reporting units. This disclosure, which excludes certain disaggregated positions, provides insight into institutional holdings in BioVie Inc.

    Stock Titan•8/7/26•
    Neutral

    Frequently Asked Questions About BIVI

    Does BIVI pay dividends?
    Biovie Inc (BIVI) does not currently pay a regular dividend.
    What is BIVI's market cap?
    Biovie Inc (BIVI) has a market capitalization of $18.25M with a current stock price of $2.28.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In